LUZHU BIOTECH-B(02480.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at loss of CNY 61.62 million, loss narrowed by 20.56% YoY
NewTimeSpace News: August 26, 2026, LUZHU BIOTECH-B(02480.HK) released its Interim Report for the period ended December 31, 2026; Net Profit stood at loss of CNY 61.62 million, loss narrowed by 20.56% YoY; Profit Attributable to Shareholders stood at loss of CNY 61.62 million, loss narrowed by 20.56% YoY; Basic Earnings Per Share (EPS) stood at loss of CNY 0.31.
In terms of profitability, LUZHU BIOTECH-B net profit changed from loss of CNY 77.57 million in the same period last year to loss of CNY 61.62 million in the current period, increased by CNY 15.95 million.
In terms of earnings quality, LUZHU BIOTECH-B Operating Profit changed from loss of CNY 74.85 million in the same period last year to loss of CNY 56.74 million in the current period, increased by CNY 18.11 million; Net Cash Flow from Operating Activities changed from cash outflow of CNY 75.29 million in the same period last year to cash outflow of CNY 45.61 million in the current period, increased by CNY 29.68 million.
In terms of financial soundness, LUZHU BIOTECH-B Debt-to-Asset Ratio changed from 31.25% in the same period last year to 39.91% in the current period, increased by 8.66 percentage points; Total Equity changed from CNY 739.131 million in the same period last year to CNY 598.497 million in the current period, decreased by CNY 140.63 million; Cash and Cash Equivalents changed from CNY 99.219 million in the same period last year to CNY 126.701 million in the current period, increased by CNY 27.48 million; Current Liabilities changed from CNY 97.64 million in the same period last year to CNY 123.57 million in the current period, increased by CNY 25.93 million; Quick Ratio changed from 4.68 in the same period last year to 3.13 in the current period, decreased by 1.55 percentage points.
In terms of R&D investment focus, LUZHU BIOTECH-B R&D Expenses changed from CNY 50.27 million in the same period last year to CNY 30.33 million in the current period, decreased by CNY 19.94 million.
By the close of trading on August 26, 2026, LUZHU BIOTECH-B(02480) saw a gain of 0.08% in its share price, closing at HKD 13.12. The full-day turnover stood at HKD 2.62 thousand, with the latest market capitalization at HKD 2.61 billion.
NewTimeSpace Disclaimer:All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
